COLL vs VMC · P/E 17, rev $181.9M vs P/E 35, rev $7.42B
Collegium Pharmaceutical Inc (COLL) versus Vulcan Materials Company (VMC) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Vulcan Materials Company (VMC) is a building materials company listed on NYSE.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported VMC revenue for 2024-12-31 was $7.42B. Net income was $913.1M. Revenue was down 4.7% from 2023-12-31 to 2024-12-31. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
Not investment advice. Open the COLL and VMC stock pages for the full models.
Not investment advice.